Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 31 AL 45

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools in the Alzheimer Disease Continuum (DDT-AD) Working Group.

Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11.

Alzheimer's disease: review of current nanotechnological therapeutic strategies

Baranowska-Wójcik E, Szwajgier D.

Expert Rev Neurother. 2020 Mar;20(3):271-279. doi: 10.1080/14737175.2020.1719069. Epub 2020 Jan 27.

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease

Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A.

Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2.

Neuroinflammation and Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches

Sung PS, Lin PY, Liu CH, Su HC, Tsai KJ.

Int J Mol Sci. 2020 Jan 21;21(3):701. doi: 10.3390/ijms21030701.

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics

Mouchlis VD, Melagraki G, Zacharia LC, Afantitis A.

Int J Mol Sci. 2020 Jan 21;21(3):703. doi: 10.3390/ijms21030703.

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Haake A, Nguyen K, Friedman L, Chakkamparambil B, Grossberg GT.

Expert Opin Drug Saf. 2020 Feb;19(2):147-157. doi: 10.1080/14740338.2020.1721456. Epub 2020 Jan 28.

Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease

Zuccarello E, Acquarone E, Calcagno E, Argyrousi EK, Deng SX, Landry DW, Arancio O, Fiorito J.

Biochem Pharmacol. 2020 Jun;176:113818. doi: 10.1016/j.bcp.2020.113818. Epub 2020 Jan 21.

"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease

Rao CV, Asch AS, Carr DJJ, Yamada HY.

Aging Cell. 2020 Mar;19(3):e13109. doi: 10.1111/acel.13109. Epub 2020 Jan 25.

Reminiscence therapy for older adults with Alzheimer's disease: A literature review

Cuevas PEG, Davidson PM, Mejilla JL, Rodney TW.

Int J Ment Health Nurs. 2020 Jun;29(3):364-371. doi: 10.1111/inm.12692. Epub 2020 Jan 26.

Effects of neural stem cell transplantation in Alzheimer's disease models

Hayashi Y, Lin HT, Lee CC, Tsai KJ.

J Biomed Sci. 2020 Jan 27;27(1):29. doi: 10.1186/s12929-020-0622-x.

Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches

Singh RK.

Curr Neuropharmacol. 2020;18(9):868-882. doi: 10.2174/1570159X18666200128121920.

Beyond amyloid: New approaches to Alzheimer's disease treatment

EBioMedicine. 2020 Jan;51:102648. doi: 10.1016/j.ebiom.2020.102648.

The Patient in Your Alzheimer's Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer's Disease

Shiovitz T, Steinmiller B, Steinmetz C, Perez S, Oseas R.

J Prev Alzheimers Dis. 2020;7(1):43-46. doi: 10.14283/jpad.2020.3.

Targeting Aggrephagy for the Treatment of Alzheimer's Disease

Malampati S, Song JX, Chun-Kit Tong B, Nalluri A, Yang CB, Wang Z, Gopalkrishnashetty Sreenivasmurthy S, Zhu Z, Liu J, Su C, Krishnamoorthi S, Iyaswamy A, Cheung KH, Lu JH, Li AM.

Cells. 2020 Jan 28;9(2):311. doi: 10.3390/cells9020311.

Sodium Oligomannate: First Approval

Syed YY.

Drugs. 2020 Mar;80(4):441-444. doi: 10.1007/s40265-020-01268-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias